Michaela Buske-Feuring
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin's lymphoma: results from the randomized international GHSG HD18 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 18, 2023
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
Journal: The Lancet. Haematology
Published: December 28, 2020
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting.
Journal: British journal of haematology
Published: December 17, 2019
The microRNA miR-196b acts as a tumor suppressor in Cdx2-driven acute myeloid leukemia.
Journal: Haematologica
Published: September 28, 2019
The ParaHox gene Cdx4 induces acute erythroid leukemia in mice.
Journal: Blood advances
Published: July 29, 2019
Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis.
Journal: Leukemia
Published: July 19, 2019
Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis.
Journal: Scientific reports
Published: April 05, 2019
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.
Journal: British journal of haematology
Published: October 09, 2018
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Journal: Lancet (London, England)
Published: May 30, 2017
Last Updated: 09/26/2026